Medicinova (MNOV) Equity Ratio (2021 - 2025)
Medicinova (MNOV) has disclosed Equity Ratio for 7 consecutive years, with 0.91 as the latest value for Q4 2025.
- On a quarterly basis, Equity Ratio changed N/A to 0.91 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.91, a N/A change, with the full-year FY2025 number at 0.91, changed N/A from a year prior.
- Equity Ratio was 0.91 for Q4 2025 at Medicinova, down from 0.92 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.96 in Q1 2021 to a low of 0.91 in Q4 2025.
- A 5-year average of 0.95 and a median of 0.95 in 2023 define the central range for Equity Ratio.
- Peak YoY movement for Equity Ratio: grew 1.77% in 2023, then dropped 2.47% in 2025.
- Medicinova's Equity Ratio stood at 0.96 in 2021, then decreased by 2.59% to 0.93 in 2022, then rose by 0.93% to 0.94 in 2023, then rose by 0.66% to 0.95 in 2024, then dropped by 3.75% to 0.91 in 2025.
- Per Business Quant, the three most recent readings for MNOV's Equity Ratio are 0.91 (Q4 2025), 0.92 (Q3 2025), and 0.94 (Q2 2025).